Clinical Trials Sponsored by TMJ Health

Total 50123 results

Cardiox Corporation
TMJ Health

Unknown

TMJ NextGen Pilot Study to Treat Subjects With Bruxism

Bruxism
TMJ Health
Cardiox Corporation

Withdrawn

TMJ-1001 Bruxism Run-In/Pivotal Trial

Bruxism
TMJ Health
Cardiox Corporation

Completed

TMJ NextGeneration(TM) Feasibility Study (Bruxoff)

Bruxism

United States
The BMJ

Completed

The Effect of Different Financial Competing Interest Statements on Readers' Perceptions of Clinical Educational Articles

Healthy
RMJ Holdings, LLC

Completed

Safety Study of RMJH-111b to Treat Essential Hypertension

Essential Hypertension

United States
TME Pharma AG

Completed

First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NOX-H94

Inflammation | Anemia | Chronic Diseases

United Kingdom
TME Pharma AG

Completed

NOX-A12 Multiple Ascending Dose Study in Healthy Volunteers (SNOXA12C101)

Hematopoietic Stem Cell Transplantation

Germany
TME Pharma AG

Completed

NOX-E36 First-in-Human (FIH) Study

Type 2 Diabetes Mellitus | Systemic Lupus Erythematosus | Chronic Inflammatory Diseases
EDAP TMS S.A.

Recruiting

Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.

Benign Prostatic Hyperplasia

France
EDAP TMS S.A.

Recruiting

Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Rectal Endometriosis (ENDO-HIFU-R1)

Endometriosis, Rectum

France
EDAP TMS S.A.

Active, not recruiting

Evaluation of the Efficacy of HIFU Treatment on Rectal Endometriosis Symptoms. (ENDO-HIFU-R2)

Endometriosis

France
TME Pharma AG

Active, not recruiting

Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients (GLORIA)

Glioblastoma

Germany
TME Pharma AG

Completed

Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Cancer

Anemia of Chronic Disease

Bulgaria, Romania, Austria
EDAP TMS S.A.

Unknown

Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer

Prostate Cancer

United States, Canada
TME Pharma AG

Completed

A Phase I Clinical Trial to Evaluate the Effect of Renal Impairment on Pharmacokinetics of NOX-E36

Renal Impairment

Hungary, Moldova, Republic of
EDAP TMS S.A.

Recruiting

ES-HIFU, Prospective Data Collection of Patients Treated With Partial Gland HIFU Ablation for Prostate Cancer (ES-HIFU)

Prostate Cancer

Spain
EDAP TMS S.A.

Unknown

Dynamic Focusing Evaluation for Prostate Cancer Treatment (FOC/DYN)

Cancer of Prostate

France
TME Pharma AG

Completed

NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

Belgium, Austria, Italy, France
TME Pharma AG

Completed

Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients

Anemia | End Stage Renal Disease

United Kingdom, Germany, Italy
TME Pharma AG

Completed

NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma

Multiple Myeloma

Austria, France, Germany, Italy
TME Pharma AG

Completed

Pharmacokinetics/Pharmacodynamics of NOX-H94 in the Human Endotoxemia Model

Anemia of Chronic Disease

Netherlands
TME Pharma AG

Completed

NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria

Type 2 Diabetes Mellitus | Albuminuria

Poland, Germany, Romania, Hungary, Czech Republic
Northwell Health
Next Science TM

Not yet recruiting

Clinical Evaluation of the Next Science SurgX Antimicrobial Wound Gel Impact on Surgical Site Complications

Total Knee Arthroplasty | Total Hip Arthroplasty

United States
Northwell Health
Next Science TM

Recruiting

Rate of Total Joint Infection 90-day After Surgery Following Irrigation With Next Science No-Rinse Solution vs SOC Alone

Joint Infection

United States
INanoBio Inc.
TMC HealthCare

Recruiting

Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 Patients (SARS-CoV-2)

COVID-19 | SARS-CoV-2 Infection

United States
Amphera BV
TMC Pharma

Completed

DENdritic Cell Immunotherapy for Mesothelioma (DENIM)

Mesothelioma

Netherlands, France, United Kingdom, Belgium, Italy
TMC HealthCare
PEEP Medical, LLC

Completed

Treating COVID-19 With a Bidirectional Oxygenation Valve

Coronavirus Infection

United States
Tmm Software
Centre Hospitalier de Vichy

Completed

Telemonitoring Impact by the ApTelecare Software in Dialysis Patient (MEDIA)

Chronic Renal Failure | Dialysis Related Complication

France
Neuronetics
Columbia University; Brown University; Sheppard Pratt Health System; NAMSA; Southern... and other collaborators

Completed

Retrospective TMS Therapy for Adults With MDD

Major Depressive Disorder (MDD)
Hospices Civils de Lyon
EDAP TMS S.A.

Recruiting

Evaluation of Different Methods of Ultrasound Image Analysis for Real-time Monitoring of HIFU Prostate Cancer Treatment (ELASTO-US)

Prostatic Neoplasms

France
TME Pharma AG
Merck Sharp & Dohme LLC

Not yet recruiting

Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer (OPTIMUS)

Metastatic Pancreatic Cancer
TME Pharma AG
Merck Sharp & Dohme LLC

Completed

Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer (Keynote-559)

Metastatic Colorectal Cancer | Metastatic Pancreatic Cancer

Germany
University of Colorado, Denver
EDAP TMS S.A.

Completed

The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer

Recurrent Prostate Cancer | Stage I Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer

United States
TME Pharma AG
Profil Institut für Stoffwechselforschung GmbH

Completed

NOX-E36 Multiple Ascending Dose Study in Healthy Volunteers and Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany
TJ Biopharma Co., Ltd.

Completed

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndromes(MDS)

China
TJ Biopharma Co., Ltd.

Withdrawn

Clinical Trial of TJ271 Injection Combined With Pembrolizumab in the Treatment of Advanced Solid Tumors

First-line Non-small-cell Lung Cancer | First-line Urothelial Carcinoma | Second-line Urothelial Carcinoma | Second-line Melanoma

China
ThinkWell
University of Oxford; Queen's University, Belfast; The BMJ

Completed

How Frequently and in What Format Are Research Trial Results Disseminated to Participants (ResponseQT) (ResponseQT)

Motivation

United Kingdom
TJ Biopharma Co., Ltd.

Recruiting

Study of Felzartamab in Healthy Adult Subjects

Healthy

China
TJ Biopharma Co., Ltd.

Recruiting

A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes(MDS)

China
TJ Biopharma Co., Ltd.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)

Newly Diagnosed Glioblastoma

China, Hong Kong
TJ Biopharma Co., Ltd.

Active, not recruiting

A Phase I/II Study of TJ004309 for Advanced Solid Tumor

Advanced Solid Tumor

China
TJ Biopharma Co., Ltd.

Terminated

A Study of Single Drug TJ011133 and Toripalimab Combine Treatment for Advanced Solid Tumor

Advanced Solid Tumor

China
TJ Biopharma Co., Ltd.

Active, not recruiting

Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors

Head and Neck Squamous Cell Carcinoma | Triple-negative Breast Cancer

China
TJ Biopharma Co., Ltd.

Terminated

A Study to Evaluate the Safety, Tolerability, and PK Profile of Single and Multiple Doses TJ202 in Patient With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE)

China
TJ Biopharma Co., Ltd.

Completed

Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TJ107 in Chinese Patients With Advanced Solid Tumors

Advanced Solid Tumord

China
TJ Biopharma Co., Ltd.

Completed

A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency

Pediatric Growth Hormone Deficiency

China
TJ Biopharma Co., Ltd.

Active, not recruiting

TJ202 Combined With Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Refractory Multiple Myeloma | Multiple Myeloma in Relapse

China, Taiwan
TJ Biopharma Co., Ltd.

Active, not recruiting

TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Refractory Multiple Myeloma | Multiple Myeloma in Relapse

China, Taiwan
MMJ Labs LLC
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

A Test of the Effectiveness of a Device and Distraction for Pediatric Immunization Pain

Procedural Pain
Universitat Politècnica de Catalunya
University of Liverpool; The BMJ

Completed

Evaluating the Impact of Assessing During Peer Review the CONSORT Checklist Submitted by Authors

Peer Review, Publishing | Completeness of Reporting

United Kingdom

3

Subscribe